Clinical Development Stocks List
Symbol | Grade | Name | % Change | |
---|---|---|---|---|
FUSN | A | Fusion Pharmaceuticals Inc. | 0.51 | |
DCPH | A | Deciphera Pharmaceuticals, Inc. | 0.04 | |
LDOS | B | Leidos Holdings, Inc. | 0.44 | |
GMED | B | Globus Medical, Inc. | 2.69 | |
REGN | B | Regeneron Pharmaceuticals, Inc. | -0.65 | |
NBIX | B | Neurocrine Biosciences, Inc. | 2.54 | |
MACK | B | Merrimack Pharmaceuticals, Inc. | 0.07 | |
NKTR | C | Nektar Therapeutics | 3.39 | |
CRVO | C | CervoMed Inc. | 0.08 | |
DCTH | C | Delcath Systems, Inc. | 1.70 |
Related Industries: Biotechnology Diagnostics & Research Drug Manufacturers - Specialty & Generic Information Technology Services Medical Devices
Symbol | Grade | Name | Weight | |
---|---|---|---|---|
BBH | B | Market Vectors Biotech ETF | 10.61 | |
PBE | B | PowerShares Dynamic Biotech & Genome | 10.35 | |
IBBQ | B | Invesco Nasdaq Biotechnology ETF | 10.0 | |
IBB | B | iShares Nasdaq Biotechnology Index Fund | 9.96 | |
MNTL | D | Tema Neuroscience and Mental Health ETF | 8.99 |
Compare ETFs
- Clinical Development
Clinical development is the process of developing a new drug, medical device, or diagnostic test from the initial concept to the point of regulatory approval. It involves a series of steps, including preclinical research, clinical trials, regulatory review, and post-marketing surveillance. The goal of clinical development is to demonstrate the safety and efficacy of a product in order to obtain regulatory approval for marketing.
Popular Now
Recent Comments
- TraderMike on IZM
- SuccessfulGerbil321 on IZM
- TraderMike on IZM
- TraderMike on Today's Outage
- Crunching_The_Market on Today's Outage
From the Blog
Featured Articles